JB, P., N, H., AEE, M., S, E., JL, B., & HJG, S. (2019). CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition. Oncotarget, 10(14), 1440. https://doi.org/10.18632/oncotarget.26677
Chicago Style (17th ed.) CitationJB, Post, Hami N, Mertens AEE, Elfrink S, Bos JL, and Snippert HJG. "CRISPR-induced RASGAP Deficiencies in Colorectal Cancer Organoids Reveal That Only Loss of NF1 Promotes Resistance to EGFR Inhibition." Oncotarget 10, no. 14 (2019): 1440. https://doi.org/10.18632/oncotarget.26677.
MLA (9th ed.) CitationJB, Post, et al. "CRISPR-induced RASGAP Deficiencies in Colorectal Cancer Organoids Reveal That Only Loss of NF1 Promotes Resistance to EGFR Inhibition." Oncotarget, vol. 10, no. 14, 2019, p. 1440, https://doi.org/10.18632/oncotarget.26677.